Yanping Zhong

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Neoadjuvant Chemotherapy

Endoplasmic Reticulum Stress

Cell Cycle Arrest

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoran Li, Yanping Zhong, Xudong Zhang, Anil K Sood, Jinsong Liu
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells. Oncogene 42 (9) (2023)
Xiaoran Li, Yanping Zhong, Xudong Zhang, Anil K Sood, Jinsong Liu
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells. Oncogene 42 (9) (2023)
Xiaoran Li, Yanping Zhong, Xudong Zhang, Anil K Sood, Jinsong Liu
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells. Oncogene 42 (9) (2023)
Xiaoran Li, Yanping Zhong, Xudong Zhang, Anil K Sood, Jinsong Liu
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells. Oncogene 42 (9) (2023)
Xiaoran Li, Yanping Zhong, Xudong Zhang, Anil K Sood, Jinsong Liu
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells. Oncogene 42 (9) (2023)
Xiaoran Li, Yanping Zhong, Xudong Zhang, Anil K Sood, Jinsong Liu
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells. Oncogene (2023)
Xiaoran Li, Yanping Zhong, Xudong Zhang, Anil K Sood, Jinsong Liu
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells. Oncogene 42 (9) (2023)
Yanping Zhong, Jinsong Liu, Xiaoran Li, Shannon N Westin, Anais Malpica, Barrett C Lawson, Sanghoon Lee, Bryan M Fellman, Robert L Coleman, Anil K Sood, Nicole D Fleming
A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma after Neoadjuvant Chemotherapy. Cancers 13 (4) (2021)